THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (GERMAN EDITION)

Transcription

1 THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (GERMAN EDITION) Feedback from 60 German patient groups PUBLISHED JUNE 2016

2 Die neuen, extrem hohen Hepatitis-C- Medikamenten-Preise haben für große Empörung und völliges Unverständnis bei uns gesorgt. Einerseits freut sich meine Organisation über jedes neue, verbesserte Medikament, aber die extremen, unverschämten Preise für die neuen Hep-C- Medikamente haben den Pharmaunternehmen insgesamt einen großen Imageschaden verursacht. Regional German patient group specialising in hepatitis and HIV/AIDS in 2016, patientview is publishing 20 corporate reputation of pharma reports, analysing the results from the 1,075 patient groups responding to the 2015 survey. specialty reports: cancer I circulatory conditions I diabetes I hiv/aids I hepatitis I neurological conditions I mental health I respiratory conditions I skin conditions I rare diseases (10 reports) geographic region reports (in addition to this current germany report): europe-wide I eastern europe I global I italy I latin america I nordic I spain I uk I us (10 reports)

3 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID GERMAN PATIENT GROUPS SAY ABOUT PHARMA IN 2015? Summary of the industry-wide findings (as judged by German patient groups) Page 3 A FEW COMMENTS ON THE GERMAN CORPORATE RANKINGS Page 6 WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION? Page 7 COMMENTS FROM GERMAN PATIENT GROUPS, 2015 Page 8 CASE STUDIES: PATIENT-GROUP RELATIONS AND PATIENT CENTRICITY AT... AbbVie Germany Bayer Page 9 METHODOLOGY OF THE PATIENT-GROUP SURVEY Page 13 QUESTIONNAIRE FOR PHARMA COMPANIES 2015 Page 14 APPENDIX 1: Data on how German patient groups see the pharmaceutical industry in 2015 Page 15 APPENDIX 2: Rankings of the 16 pharma companies for each of the 6 indicators of corporate reputation, as perceived by German patient groups in 2015 Page 20 APPENDIX 3: Profiles of the 16 companies Page 29 APPENDIX 4: Profiles of the 60 respondent German patient groups Page 47

4 LIST OF TABLES AND CHARTS BASED ON THE VIEWS OF GERMAN PATIENT GROUPS, 2015 Percentage of German patient groups claiming familiarity with the company Page 2 Percentage of German patient groups claiming familiarity with the company, and which also worked with it Page 2 Percentage of patient groups worldwide (by geographic region) stating that the pharma industry had an Excellent or Good corporate reputation in 2015 Percentage of patient groups worldwide (by geographic region) stating that pharma was Excellent or Good at MAKING USEFUL PRODUCTS in 2015 Percentage of patient groups worldwide (by geographic region) stating that pharma was Excellent or Good at HAVING INTEGRITY in 2015 Percentage of patient groups worldwide (by geographic region) stating that pharma was Excellent or Good at HAVING FAIR PRICING POLICIES in 2015 Final ranking of 16 pharma companies in Germany, 2015, according to German patient groups (v. final ranking of 14 pharma companies in Germany, 2014) If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow? Please select only ONE option How do you think your organisation s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015? Page 3 Page 5 Page 5 Page 5 Page 6 Page 7 Page 16 What do you think has happened to the corporate reputation of the pharma industry over the past five years? Page 17 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Page 18 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)? Page 19 Companies with the most effective patient-centred strategy (rankings of 16 companies, 2015) Page 21 Companies providing the best high-quality patient information (rankings of 16 companies, 2015) Page 22 Companies with the best record on patient safety (rankings of 16 companies, 2015) Page 23 Companies with the most-useful high-quality products (rankings of 16 companies, 2015) Page 24 Companies with the best record of transparency (rankings of 16 companies, 2015) Page 25 Companies with the best record on integrity (rankings of 16 companies, 2015) Page 26 Rankings of the 16 pharmaceutical companies in 2015, ALPHABETIC ORDER Page 27 Rankings of the 16 pharmaceutical companies in 2015, HIGHEST TO LOWEST Page 28 Main specialisations of 2015 s 60 respondent German patient groups Page 48 Geographic remit of 2015 s 60 respondent German patient groups Page 48

5 LIST OF TABLES AND CHARTS CONTINUED AstraZeneca page 31 Bayer page 32 Boehringer Ingelheim page 33 B-MS page 34 Eli Lilly page 35 Grünenthal page 36 GSK page 37 Janssen page 38 Merck & Co (US) page 39 Merck KGaA page 40 Novartis page 41 Pfizer page 42 Roche page 43 Sandoz page 44 Sanofi page 45 Stada Arzneimittel page 46 profiles of the 16 companies, according to the german patient groups familiar with these companies, or which have worked with them Each profile contains... company background information Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. = increase in revenue over the previous year or = decrease in revenue. The profiled company s main treatment subject areas (and areas of R&D). A mission statement from the profiled company. how the company has performed at six indicators of corporate reputation The profiled company s performance at the six indicators of corporate reputation in 2015, according to the German patient groups familiar with the company. The profiled company s performance at the six indicators of corporate reputation, according to the German patient groups that have worked with the company. how the company ranks for corporate reputation compared with other companies The profiled company s rankings among German patient groups in 2015 for the six indicators of corporate reputation, compared with 15 other companies. The profiled company s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies. profile of the patient groups familiar with the company Other companies that partner with a significant number of the profiled company s partner patient groups. The countries of the patient groups familiar with the profiled company. Janssen Pharmaceutical Companies of Johnson & Johnson

6 Contact details PatientView Registered office: One Fleet Place, London, EC4M 7WS, UK Tel: +44-(0) Registered in England, number: Data protection registration number: Z VAT registration number: GB Copyright 2016 PatientView Ltd. All rights reserved. This booklet is the property of PatientView, and no part may be reproduced without permission, or passed on to any third party without the permission of PatientView.